Q3 2024 · 13F-HR
Ikarian Capital, LLCholdings as filed
Filed 2024-11-14 · accession 0001420506-24-002562
$717.2M
Reported value
145
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 78464A870 | XBI | SPDR SER TR | $49.4M | 6.89% | 500,000 | PUT | SOLE |
| 031162100 | AMGN | AMGEN INC | $47.0M | 6.56% | 146,000 | CALL | SOLE |
| 92532F100 | VRTX | VERTEX PHARMACEUTICALS INC | $46.5M | 6.49% | 100,000 | PUT | SOLE |
| 92532F100 | VRTX | VERTEX PHARMACEUTICALS INC | $46.5M | 6.49% | 100,000 | CALL | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $33.9M | 4.73% | 1,030,277 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $21.8M | 3.04% | 426,913 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $16.6M | 2.31% | 365,200 | PUT | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $16.3M | 2.27% | 325,600 | PUT | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $14.3M | 1.99% | 500,000 | CALL | SOLE |
| 032724106 | ANAB | ANAPTYSBIO INC | $13.5M | 1.89% | 404,300 | PUT | SOLE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $12.8M | 1.78% | 499,566 | Common | SOLE |
| 032724106 | ANAB | ANAPTYSBIO INC | $11.7M | 1.63% | 350,000 | CALL | SOLE |
| 03969F109 | RCUS | ARCUS BIOSCIENCES INC | $11.4M | 1.59% | 744,000 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $11.4M | 1.59% | 499,977 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $11.3M | 1.58% | 154,835 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $11.2M | 1.56% | 221,437 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $10.4M | 1.45% | 305,500 | PUT | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $10.4M | 1.45% | 305,500 | CALL | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $9.9M | 1.39% | 179,000 | Common | SOLE |
| 05338F306 | AVTX | AVALO THERAPEUTICS INC | $9.2M | 1.29% | 970,359 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $9.0M | 1.25% | 170,147 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $8.9M | 1.24% | 302,247 | Common | SOLE |
| 14888U101 | CPRX | CATALYST PHARMACEUTICALS INC | $8.3M | 1.16% | 417,850 | Common | SOLE |
| 878972108 | TECX | TECTONIC THERAPEUTIC INC | $8.1M | 1.13% | 267,145 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $7.9M | 1.10% | 85,000 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $7.3M | 1.01% | 285,613 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $6.8M | 0.94% | 54,176 | Common | SOLE |
| 07725L102 | ONC | BEIGENE LTD | $6.7M | 0.93% | 29,800 | CALL | SOLE |
| 21833P301 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $5.9M | 0.82% | 284,715 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $5.8M | 0.81% | 260,000 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $5.8M | 0.80% | 200,000 | PUT | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $5.7M | 0.80% | 198,900 | PUT | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $5.6M | 0.77% | 110,000 | CALL | SOLE |
| 670703107 | NUVL | NUVALENT INC | $5.3M | 0.75% | 52,238 | Common | SOLE |
| 640979100 | NMRA | NEUMORA THERAPEUTICS INC. | $5.3M | 0.74% | 400,000 | CALL | SOLE |
| 640979100 | NMRA | NEUMORA THERAPEUTICS INC. | $5.3M | 0.74% | 400,000 | PUT | SOLE |
| 02157Q109 | ANRO | ALTO NEUROSCIENCE INC | $5.1M | 0.72% | 450,000 | PUT | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $5.1M | 0.71% | 115,200 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $5.0M | 0.70% | 23,500 | PUT | SOLE |
| 02157Q109 | ANRO | ALTO NEUROSCIENCE INC | $4.9M | 0.69% | 431,000 | CALL | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $4.9M | 0.68% | 693,350 | Common | SOLE |
| 52635N103 | LENZ | LENZ THERAPEUTICS INC | $4.9M | 0.68% | 204,513 | Common | SOLE |
| 21833P301 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $4.8M | 0.67% | 233,100 | PUT | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $4.8M | 0.67% | 133,000 | PUT | SOLE |
| 14070B309 | CAPR | CAPRICOR THERAPEUTICS INC | $4.6M | 0.64% | 300,000 | PUT | SOLE |
| 14070B309 | CAPR | CAPRICOR THERAPEUTICS INC | $4.6M | 0.64% | 300,000 | CALL | SOLE |
| 14070B309 | CAPR | CAPRICOR THERAPEUTICS INC | $4.6M | 0.64% | 300,000 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $4.5M | 0.63% | 200,000 | CALL | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $4.5M | 0.62% | 544,265 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $4.3M | 0.60% | 150,000 | CALL | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $4.3M | 0.60% | 887,230 | Common | SOLE |
| 031162100 | AMGN | AMGEN INC | $4.3M | 0.60% | 13,300 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $4.2M | 0.59% | 107,187 | Common | SOLE |
| 30052C107 | EOLS | EVOLUS INC | $4.2M | 0.58% | 258,279 | Common | SOLE |
| 09203E105 | BDTX | BLACK DIAMOND THERAPEUTICS I | $4.1M | 0.58% | 950,000 | PUT | SOLE |
| 00289Y206 | ABEO | ABEONA THERAPEUTICS INC | $3.7M | 0.51% | 583,593 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $3.6M | 0.51% | 197,096 | Common | SOLE |
| 747324101 | PYXS | PYXIS ONCOLOGY INC | $3.5M | 0.49% | 957,408 | Common | SOLE |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $3.4M | 0.47% | 587,343 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $3.3M | 0.47% | 677,074 | Common | SOLE |
| 23256X407 | HELP | CYBIN INC | $3.3M | 0.46% | 367,195 | Common | SOLE |
| 09203E105 | BDTX | BLACK DIAMOND THERAPEUTICS I | $3.0M | 0.42% | 700,000 | CALL | SOLE |
| 15713L109 | CRVO | CERVOMED INC | $3.0M | 0.41% | 202,345 | Common | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $2.8M | 0.39% | 108,483 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $2.8M | 0.39% | 52,300 | CALL | SOLE |
| 799566104 | SANA | SANA BIOTECHNOLOGY INC | $2.7M | 0.38% | 650,000 | PUT | SOLE |
| 799566104 | SANA | SANA BIOTECHNOLOGY INC | $2.7M | 0.38% | 650,000 | CALL | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $2.6M | 0.36% | 308,497 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $2.4M | 0.34% | 8,741 | Common | SOLE |
| 52886X107 | LXEO | LEXEO THERAPEUTICS INC | $2.3M | 0.32% | 257,216 | Common | SOLE |
| 21833P301 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $2.2M | 0.31% | 107,800 | CALL | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $2.2M | 0.30% | 180,000 | Common | SOLE |
| 83422E204 | SLDB | SOLID BIOSCIENCES INC | $2.1M | 0.29% | 300,000 | CALL | SOLE |
| 75974E103 | — | RENEO PHARMACEUTICALS INC | $1.7M | 0.24% | 1,025,668 | Common | SOLE |
| 03969F109 | RCUS | ARCUS BIOSCIENCES INC | $1.7M | 0.24% | 113,700 | CALL | SOLE |
| 640268108 | NKTREUR | NEKTAR THERAPEUTICS | $1.7M | 0.24% | 1,312,405 | Common | SOLE |
| 61225M102 | GLUE | MONTE ROSA THERAPEUTICS INC | $1.7M | 0.23% | 311,593 | Common | SOLE |
| 07725L102 | ONC | BEIGENE LTD | $1.6M | 0.23% | 88,167 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $1.6M | 0.23% | 202,100 | PUT | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $1.6M | 0.23% | 202,100 | CALL | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $1.5M | 0.21% | 422,800 | CALL | SOLE |
| 00449L102 | 698 | ACHILLES THERAPEUTICS PLC | $1.5M | 0.21% | 1,443,181 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $1.4M | 0.20% | 43,800 | CALL | SOLE |
| 363225202 | GALT | GALECTIN THERAPEUTICS INC | $1.4M | 0.19% | 500,000 | PUT | SOLE |
| 363225202 | GALT | GALECTIN THERAPEUTICS INC | $1.4M | 0.19% | 500,000 | CALL | SOLE |
| 451033708 | IBIO | IBIO INC | $1.3M | 0.19% | 600,000 | Common | SOLE |
| 747324101 | PYXS | PYXIS ONCOLOGY INC | $1.3M | 0.18% | 358,600 | CALL | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $1.3M | 0.18% | 202,908 | Common | SOLE |
| 50015M109 | KOD | KODIAK SCIENCES INC | $1.2M | 0.17% | 476,586 | Common | SOLE |
| 56854Q200 | MRNS* | MARINUS PHARMACEUTICALS INC | $1.2M | 0.17% | 706,154 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $1.2M | 0.16% | 100,609 | Common | SOLE |
| 221015100 | CRVS | CORVUS PHARMACEUTICALS INC | $1.2M | 0.16% | 218,300 | CALL | SOLE |
| 68062P106 | OLMA | OLEMA PHARMACEUTICALS INC | $1.1M | 0.15% | 92,000 | Common | SOLE |
| N44821101 | IFRX | INFLARX NV | $1.1M | 0.15% | 704,987 | Common | SOLE |
| 786700104 | SGMT | SAGIMET BIOSCIENCES INC | $1.1M | 0.15% | 387,565 | Common | SOLE |
| 471871202 | JSPR | JASPER THERAPEUTICS INC | $1.0M | 0.14% | 55,175 | Common | SOLE |
| 46489V302 | CATX | PERSPECTIVE THERAPEUTICS INC | $1.0M | 0.14% | 77,100 | PUT | SOLE |
| 09090D301 | — | BIOMX INC | $910,860 | 0.13% | 893,000 | Common | SOLE |
| 24661P807 | DCTH | DELCATH SYS INC | $906,340 | 0.13% | 100,370 | Common | SOLE |
| 28658R106 | CLYM | ELIEM THERAPEUTICS INC | $891,258 | 0.12% | 175,100 | Common | SOLE |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $889,546 | 0.12% | 274,551 | Common | SOLE |
| N71542109 | PRQR | PROQR THRAPEUTICS N V | $880,121 | 0.12% | 483,583 | Common | SOLE |
| 816212302 | RNAC | CARTESIAN THERAPEUTICS INC | $841,352 | 0.12% | 52,193 | Common | SOLE |
| 49372L100 | — | KEZAR LIFE SCIENCES INC | $826,544 | 0.12% | 1,068,992 | Common | SOLE |
| 92539P101 | — | VERVE THERAPEUTICS INC | $822,800 | 0.11% | 170,000 | Common | SOLE |
| 4525EP101 | VTLUSD | IMMUNIC INC | $814,268 | 0.11% | 493,496 | Common | SOLE |
| 46565G104 | 5E7 | ITEOS THERAPEUTICS INC | $802,241 | 0.11% | 78,574 | Common | SOLE |
| 008064107 | — | AEROVATE THERAPEUTICS INC | $769,046 | 0.11% | 367,965 | Common | SOLE |
| 92536C103 | VERUEUR | VERU INC | $727,767 | 0.10% | 946,382 | Common | SOLE |
| 55083R104 | — | LYELL IMMUNOPHARMA INC | $725,971 | 0.10% | 526,066 | Common | SOLE |
| 59935V107 | MIST | MILESTONE PHARMACEUTICALS IN | $708,349 | 0.10% | 466,019 | Common | SOLE |
| 00509G209 | ABOS | ACUMEN PHARMACEUTICALS INC | $660,759 | 0.09% | 266,435 | Common | SOLE |
| 45720N103 | INBX | INHIBRX BIOSCIENCES INC | $659,646 | 0.09% | 42,123 | Common | SOLE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $635,352 | 0.09% | 972,675 | Common | SOLE |
| N44445109 | IMTX | IMMATICS N.V | $563,825 | 0.08% | 49,415 | Common | SOLE |
| 09077A106 | BMEA | BIOMEA FUSION INC | $535,300 | 0.07% | 53,000 | PUT | SOLE |
| B6S7WD106 | NYXH | NYXOAH S A | $484,175 | 0.07% | 50,699 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $483,060 | 0.07% | 29,100 | CALL | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $419,970 | 0.06% | 192,647 | Common | SOLE |
| 28623U101 | — | ELEVATION ONCOLOGY INC | $413,984 | 0.06% | 690,089 | Common | SOLE |
| 81728A108 | SNSEEUR | SENSEI BIOTHERAPEUTICS INC | $388,700 | 0.05% | 650,000 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $383,358 | 0.05% | 58,528 | Common | SOLE |
| 60255C885 | BRD1EUR | MIND MEDICINE MINDMED INC | $355,516 | 0.05% | 62,481 | Common | SOLE |
| 48576U106 | KPTIEUR | KARYOPHARM THERAPEUTICS INC | $339,764 | 0.05% | 409,355 | Common | SOLE |
| 16385C104 | — | CHEMOMAB THERAPEUTICS LTD | $335,025 | 0.05% | 213,392 | Common | SOLE |
| 92915B106 | VYGR | VOYAGER THERAPEUTICS INC | $326,763 | 0.05% | 55,857 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $310,796 | 0.04% | 154,625 | Common | SOLE |
| 034569103 | ANEB | ANEBULO PHARMACEUTICALS INC | $304,675 | 0.04% | 157,862 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $293,700 | 0.04% | 5,000 | CALL | SOLE |
| 74365U107 | TARA | PROTARA THERAPEUTICS INC | $284,953 | 0.04% | 155,712 | Common | SOLE |
| 55234L105 | LYRAGBP | LYRA THERAPEUTICS INC | $271,606 | 0.04% | 1,056,829 | Common | SOLE |
| 00791X100 | — | AEON BIOPHARMA INC | $270,876 | 0.04% | 257,977 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $267,750 | 0.04% | 75,000 | Common | SOLE |
| 556099109 | MGNX | MACROGENICS INC | $263,460 | 0.04% | 80,079 | Common | SOLE |
| 43906K209 | HOOK | HOOKIPA PHARMA INC | $228,227 | 0.03% | 53,076 | Common | SOLE |
| G72800108 | PRTA | PROTHENA CORP PLC | $197,414 | 0.03% | 11,800 | CALL | SOLE |
| G72800108 | PRTA | PROTHENA CORP PLC | $197,414 | 0.03% | 11,800 | PUT | SOLE |
| 67080N101 | NUVB | NUVATION BIO INC | $190,716 | 0.03% | 83,282 | Common | SOLE |
| 87978U108 | OVASUSD | TEMPEST THERAPEUTICS INC | $147,840 | 0.02% | 105,600 | Common | SOLE |
| 75955J402 | RLMD | RELMADA THERAPEUTICS INC | $130,795 | 0.02% | 40,369 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $83,768 | 0.01% | 6,816 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $81,396 | 0.01% | 22,800 | PUT | SOLE |
| 87166L209 | SYBX | SYNLOGIC INC | $30,468 | 0.00% | 20,448 | Common | SOLE |
| 23284F105 | CTMX | CYTOMX THERAPEUTICS INC | $10,529 | 0.00% | 8,924 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $421 | 0.00% | 39 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.